Literature DB >> 34754585

Endoscopic resection of supergiant pituitary adenoma.

Federica Penner1, Giuseppe Di Perna1, Bianca Maria Baldassarre1, Diego Garbossa1, Francesco Zenga1.   

Abstract

BACKGROUND: Giant pituitary adenomas are a rare finding and the literature is inconclusive regarding the most appropriate approach. In supergiant adenomas, where the size of the tumor is exceptional, both a combine approach versus a solely transcranial or endoscopic approach have been reported.[2,3,5]. CASE DESCRIPTION: In this video, an entirely endoscopic resection of a supergiant pituitary adenoma is demonstrated. The exceptional size (4.5 × 5.8 × 5.4 cm) of the tumor and the peculiarity of the anatomical relations are documented in the video. The anterior cerebral arteries, both the A1 and A2 tracts, as well as the anterior communicating arteries are shown to be posteriorly dislocated and encased by the tumor which is pealed from the arteries themselves. Furthermore, the optic nerves are decompressed and cleaned from any residual tumor. The procedure is highly technically challenging since the furthermost part of the adenoma is also the one attached to the great intracranial arteries. A 45 optic and angle instruments were used for the major part of the surgery. Considering the high risk of postoperative CSF leak, a multilayer closure with nasoseptal flap was chosen. The postoperative MRI showed a gross total resection of the lesion in the absence of any complications and no new neurological nor endocrinological deficit appeared.
CONCLUSION: Expanded endoscopic endonasal approach could represent a valuable way to face giant adenoma, providing a direct corridor toward the lesion and safe control of both the chiasmatic vasculature and the anterior communicating artery complex. Multilayer reconstruction is mandatory to avoid postoperative CSF leak.[1,4]. Copyright:
© 2021 Surgical Neurology International.

Entities:  

Year:  2021        PMID: 34754585      PMCID: PMC8571212          DOI: 10.25259/SNI_630_2021

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


[Video 1]-Available on:

www.surgicalneurologyint.com

Annotations[1-5]

00:07 – Clinical Presentation 00:23 – Neurological Examination 00:36 – Neuro-Imaging Findings 01:05 – Surgical Alternatives 01:28 – Surgical Positioning 01:31 – Necessary Equipment 03:29 – Tumor Debulking 05:17 – Optic Nerves Decompression 05:31 – Tumor Dissection from Anterior Cerebral Artery and Anterior Communicating Artery 06:14 – Clinical Outcome 06:25 – Disease Background 06:35 – Radiological Outcome.
  5 in total

1.  Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.

Authors:  Tural Rahimli; Tural Hidayetov; Zerife Yusifli; Hidayet Memmedzade; Tural Rajabov; Kamran Aghayev
Journal:  World Neurosurg       Date:  2021-01-29       Impact factor: 2.104

2.  Super Giant Growth Hormone-Secreting Pituitary Adenoma in Young Woman: From Ventricles to Nose.

Authors:  Federica Penner; Nunzia Prencipe; Valentina Pennacchietti; Paolo Pacca; Valeria Cambria; Diego Garbossa; Francesco Zenga
Journal:  World Neurosurg       Date:  2018-11-22       Impact factor: 2.104

3.  Impact of Multilayer Vascularized Reconstruction after Skull Base Endoscopic Endonasal Approaches.

Authors:  Juan Antonio Simal-Julián; Pablo Miranda-Lloret; Laila Pérez de San Román Mena; Pablo Sanromán-Álvarez; Alfonso García-Piñero; Rosa Sanchis-Martín; Carlos Botella-Asunción; Amin Kassam
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-28

4.  Surgical management of pituitary adenomas: does age matter?

Authors:  Valentina Tardivo; Federica Penner; Diego Garbossa; Giuseppe Di Perna; Paolo Pacca; Luca Salvati; Roberto Altieri; Silvia Grottoli; Francesco Zenga
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

5.  Skull base reconstruction: A question of flow? A critical analysis of 521 endoscopic endonasal surgeries.

Authors:  Giuseppe Di Perna; Federica Penner; Fabio Cofano; Raffaele De Marco; Bianca Maria Baldassarre; Irene Portonero; Diego Garbossa; Luca Ceroni; Giancarlo Pecorari; Francesco Zenga
Journal:  PLoS One       Date:  2021-03-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.